Dr M and AVXL have wised up after the disaster this last November. They are being more mindful of the statements they make, when they release PRs, and how they're dealing with data. This is better in the short term and the long term. Nothing indicates, this far, that the data is bad. IR addressed the delay in data in the email response that many have seen here. Given the 104 week extension and plans for a phase 2/3 for AD and Retts, 2-73 is at minimum showing some type of progress in the AD patients.
News 
Market Data 
Discover 
